Revision of the Smoker's Paradox: Smoking is not a Good Prognostic Factor Immediately after Myocardial Infarction;Révision du «paradoxe du fumeur»: Le tabac n'est pas un facteur de bon pronostic au décours immédiat de l'infarctus du myocarde

Archives des Maladies du Coeur et des Vaisseaux

Volumn 94, Issue 4, 2001, Pages 262-268

  Himbert, D ^a   Juliard, J M ^a   Golmard, J L ^b   Feldman, L J ^a   Aubry, P ^a   Benamer, H ^a   Karila Cohen, D ^a   Gauci, L ^a   Steg, P G ^a  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOGENIC SHOCK; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REGRESSION ANALYSIS; REPERFUSION INJURY; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; REGRESSION ANALYSIS; REPERFUSION INJURY; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; SMOKING;

EID: 0035317221     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kannel WB, McGee DL, Gastelli WP. Latest perspective on cigarette smoking and cardiovascular disease: the Framingham Study. J Cardiac Rehabil 1984 ; 4 : 267-77.
2. Jensen G, Nyboe J, Appleyard M, Schnohr P. Risk factors for acute myocardial infarction in Copenhagen II: smoking, alcohol intake, physical inactivity, obesity, oral contraception, diabetes, lipids and blood pressure. Eur Heart J 1991 ; 12 : 298-308.
3. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336 : 1276-82.
4. Burke AP, Forb A, Malcom GT et al. Effect of risk factors on the mechanism of acute thrombosis and suden coronary death in women. Circulation 1998 ; 97 : 2110-6.
5. Prescott E. Hippe M, Schnohr P, Hein HO, Vestbo J. Smoking and risk of myocardial infarction in women and men : longitudinal population study. BMJ 1998 ; 316 : 1043-7.
6. Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Ciculation 1999 ; 23 : 1411-5.
7. Barbash GI, Reiner J, White HD et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the «smoker's paradox» from the GUSTO-1 trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary arteries. J Am Coll Cardiol 1995 ; 26 : 1222-9.
8. Barbash GI, White HD, Modan M et al. for the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Significance of smoking in patients receiving thrombolytic therapy ror acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993 ; 87 : 53-8.
9. Grines CL, Topol EJ, O'Neill WW et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995 ; 91 : 298-303.
10. Zahger D, Cercek B. Cannon CP et al. for the TIMI-4 Investigators. How do smokers differ from nonsmokers in their response to thrombolysis? (The TIMI-4 Trial). Am J Cardiol 1995 ; 75 : 232-6.
11. Ishihara M, Sato H, Tateishi H et al. Clinical implications of cigarette smoking in acute myocardial infarction: acute angioqraphic findings and long-term prognosis. Am Heart J 1997 ; 134 : 955-60
12. Lundergan CF, Reiner JS, McCarthy WF, Coyne KS, Califf RM, Ross AM, for the GUSTO-1 Angiographic Investigators. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrornbolytic regimen: The GUSTO-1 experience. J Am Coll Cardiol 1998 ; 32 : 641-7.
13. Ise KL, Woodlief JH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-1 Investigators. Circulation 1995 ; 91 : 1659-68.
14. Jorgensen C, Kober L, Ottesen MM, Torp-Pedersen C, Videbaek J, Kjoller E. The prognostic importance of smoking status at the time of acute myocardial infarction in 6676 patients. J Cardiovasc Risk 1999 ; 6 : 23-7.
15. Barbash GI, White HD, Modan M et al, for the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Acute myocardial infarction in the young - the role of smoking. Eur Heart J 1995 ; 16 : 313-6.
16. Maggioni AP, Piantadosi F, Tognoni G, Santoro E, Franzosi MG. Smoking is not a protective factor for patients with acute myocardial infarction: the viewpoint of the GISSI-2 Study. G Ital Cardiol 1998 ; 28 : 970-8.
17. Njolstad I, Arnesen E. Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: a prospective analysis from the Finnmark Study. Arch Intern Med 1998 ; 158 : 1326-32.
18. de Chillou C, Riff P, Sadoul N et al. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis. J Am Coll Cardiol 1996 ; 27 : 1662-8.
19. Pfeffer MA, Moyé LA, Braunwald E, Cuddy TE. Selection bias in the use of thrombolytic therapy in acute myocardial infarction. JAMA 1991 ; 266 : 528-32.
20. Juliard JM, Himbert D, Aubry P et al. Prise en charge orientée vers la reperfusion en phase aiguë d'infarctus du myocarde. Résultats consécutifs sur une cohorte de 700 patients consécutifs. Arch Mal Cœur 1997 ; 90 : 337-43.
21. Juliard JM, Himbert D, Golmard JL et al. Can we provide reperfusion therapy to all unselected patients admitted with acute myocordial infarction? J Am Coll Cardiol 1997 ; 30 : 157-64.
22. Fumival GM, Wilson WR. Regressions by leaps and bounds. Technometrics 1974 ; 16 : 499-511.
23. Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York: Wiley, 1989.
24. Gomez MA, Karagounis LA, Allen A et al. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. Am J Cardiol 1993 ; 72 : 373-8.
25. Hasdai D, Rihal CS, Lerman A, Grill DE, Holmes Jr DR. Smokers undergoing percutaneous coronary revascularization present with fewer narrowings in the target coronary artery. Am J Cardiol 1997 ; 80 : 1212-4.
26. Bowers TR, Terrien EF, O'Neill WW, Sachs D, Grines CL, for the PAMI Investigators. Effect of reperfusion modalities in nonsmokers and smokers with acute myocardial infarction (A Primary Angioplasty in Myocardial Infarction [PAMI] substudy). Am J Cardiol 1996 ; 78 : 511-5.
27. Hasdai D, Lerman A, Rihal CS, et al. Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction. Am Heart J 1999 ; 137 : 612-20.
28. Hansen EF, Andersen LT, Von Eyben FE. Cigarette smoking and age at first acute myocardial infarction, and influence of gender and extent of smoking. Am J Cardiol 1993 ; 71 : 1439-42.
29. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM, for the National Registry of Myocardial Infarction 2 Participants. Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999 ; 341 : 217-25.
30. Gottlieb S, Fallavollita J, McDermott M, Brown M, Eberly S, Moss AJ. Cigarette smoking and the age at onset of a firsf non-fatal myocardial infarction. Coron Artery Dis 1994 ; 5 : 687-94.